Home> Products> bone resorption leading

{ "products": [ { "_id": "6822f6b2ab5024c71f211f50", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "zoledronic acid injection", "description": "ZOLMIGRAN is a powerful intravenous medication containing Zoledronic Acid 5mg, designed to treat and prevent bone-related complications in various conditions such as osteoporosis, Paget’s disease of bone, and cancers that affect bones. It belongs to a class of drugs known as bisphosphonates, which help in strengthening bones, reducing bone loss, and preventing fractures. ZOLMIGRAN is often recommended when oral treatments are ineffective or not well-tolerated.\n\nKey Ingredients\nZoledronic Acid (5mg): The active pharmaceutical ingredient responsible for inhibiting bone resorption and maintaining bone density.\n\nKey Benefits\nHelps in the treatment of osteoporosis in postmenopausal women and men at high risk of fractures.\n\nEffective in treating Paget's disease of bone, promoting normal bone formation.\n\nReduces the risk of bone fractures in patients with cancer that has spread to bones.\n\nPrevents skeletal-related events (SREs) like bone pain, fractures, and spinal cord compression in metastatic bone diseases.\n\nOffers a once-yearly infusion for osteoporosis, improving patient compliance.\n\nHow Does It Work?\nZOLMIGRAN works by binding strongly to the bone surface, specifically at sites of active resorption. Zoledronic Acid inhibits the activity of osteoclasts, the cells responsible for breaking down bone tissue. By reducing osteoclast activity, it slows down the process of bone resorption, leading to increased bone mass and strength. This action helps in stabilizing bone structure, reducing the likelihood of fractures and other bone complications.\n\nDirections for Use\nZOLMIGRAN is administered as an intravenous infusion by a healthcare professional.\n\nThe usual dosage for osteoporosis is a single 5mg infusion once a year.\n\nFor Paget's disease of bone, a single 5mg infusion is typically sufficient.\n\nAdequate hydration before and after the infusion is recommended.\n\nCalcium and vitamin D supplementation may be prescribed to support bone health.\n\nFollow your doctor’s specific instructions regarding dosage and frequency.\n\nSide Effects\nCommon side effects include flu-like symptoms such as fever, chills, muscle pain, and joint pain after infusion.\n\nMay cause headache, fatigue, and nausea.\n\nCan lead to low blood calcium levels (hypocalcemia), which may require supplementation.\n\nPossible kidney function impairment, especially in patients with pre-existing conditions.\n\nRarely, osteonecrosis of the jaw (ONJ) and atypical femur fractures can occur with long-term use.\n\nAlways inform your doctor of any side effects experienced post-infusion.", "price": 3500.0, "discountamount": 1050.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "require supplementation", "recommended calcium", "usual dosage", "high risk", "jaw onj", "headache fatigue", "flulike symptoms", "healthcare professional", "action helps", "cells responsible", "binding strongly", "onceyearly infusion", "postmenopausal women", "oral treatments", "affect bones", "fractures effective", "bone tissue", "joint pain", "intravenous infusion", "bone fractures", "pagets disease", "osteoporosis pagets disease", "bone pain fractures", "preventing fractures zolmigran", "single 5mg infusion", "reducing osteoclast activity", "treating pagets disease", "atypical femur fractures", "work zolmigran works", "bone complications directions", "increased bone mass", "bone resorption leading", "bone surface specifically", "inhibiting bone resorption", "powerful intravenous medication", "kidney function impairment", "doctors specific instructions", "spinal cord compression", "prevent bonerelated complications" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2110, "imageuri": "https://productimages.withfloats.com/actual/6822f6b37108c6234142be46.png", "tileimageuri": "https://productimages.withfloats.com/tile/6822f6b37108c6234142be46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-13T07:37:22.447Z", "updatedon": "2026-03-16T06:23:41.397Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/zoledronic-acid-injection/2110", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ZOLMIGRAN", "category": "ORTHOLOGYRANG", "tags": [ "Zoledronic acid Injection cost", "Zoledronic acid Injection dose", "Zoledronic acid Injection price", "Zoledronic acid infusion protocol", "Zoledronic Acid Injection price in India", "Zoledronic acid injection uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6666d20b54b2801048924817", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "IBANDZONIC 150 ", "description": "IBANDZONIC 150 \nIbandronate Sodium (150mg)\nIntroduction\nIBANDZONIC 150 contains Ibandronate Sodium (150mg), a potent bisphosphonate medication used to prevent and treat osteoporosis in postmenopausal women. Osteoporosis is a condition characterized by weakened bones and an increased risk of fractures. Ibandronate Sodium works by inhibiting bone resorption, leading to increased bone mineral density and reduced fracture risk.\n\nKey Ingredient and Its Benefits\nIbandronate Sodium (150mg)\nInhibits Bone Resorption: Ibandronate Sodium is a bisphosphonate that slows down or prevents bone resorption, a process where bone tissue is broken down and minerals are released into the blood. This helps to maintain or increase bone density.\nIncreases Bone Density: By inhibiting bone resorption, Ibandronate Sodium helps increase bone mineral density, making bones stronger and less prone to fractures.\nReduces Fracture Risk: Clinical studies have shown that Ibandronate Sodium significantly reduces the risk of vertebral and non-vertebral fractures in postmenopausal women with osteoporosis.\nBenefits of IBANDZONIC 150\nPrevents and Treats Osteoporosis: IBANDZONIC 150 is effective in both the prevention and treatment of osteoporosis, helping to maintain bone health in postmenopausal women.\nIncreases Bone Strength: By increasing bone mineral density, IBANDZONIC 150 strengthens bones, reducing the risk of fractures.\nConvenient Monthly Dosing: The once-monthly dosing regimen of IBANDZONIC 150 offers convenience and improves adherence compared to more frequent dosing schedules.\nProven Efficacy: Clinical trials have demonstrated the efficacy of Ibandronate Sodium in reducing fracture risk and improving bone density.\nDosage and Administration\nDosage\nRecommended Dosage: The typical dosage of IBANDZONIC 150 for the prevention and treatment of osteoporosis is one tablet taken once a month. The exact dosage and duration of treatment should be determined by a healthcare provider based on individual patient needs.\nAdministration\nOral Use: Take the tablet whole with a full glass of plain water (6-8 ounces) on an empty stomach. Avoid lying down for at least 60 minutes after taking the medication to prevent esophageal irritation.\nTiming: Take IBANDZONIC 150 at least 60 minutes before consuming any food, beverages (other than plain water), or other medications or supplements.\nConsistency: For optimal results, take the medication on the same date each month to maintain a consistent dosing schedule.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \nBUY NOW\nhttps://www.sterisonline.com/product/ibandzonic-150-134171", "price": 221.0, "discountamount": 66.3, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "BUY", "food", "bones", "blood", "150mg", "EMAIL", "Timing", "Treats", "process", "Inhibits", "weakened", "duration", "Prevents", "minerals", "Oral Use", "Benefits", "beverages", "condition", "same date", "increased", "adherence", "treatment", "full glass", "IBANDZONIC", "prevention", "one tablet", "60 minutes", "supplements", "bone health", "bone tissue", "convenience", "Consistency", "information", "plain water", "osteoporosis", "Introduction", "exact dosage", "sterisonline", "sterispharma", "bone density", "CALL/WHATSAPP", "Bone Strength", "fracture risk", "empty stomach", "typical dosage", "Key Ingredient", "Clinical trials", "Proven Efficacy", "bone resorption", "optimal results", "Clinical studies", "other medications", "Ibandronate Sodium", "Recommended Dosage", "healthcare provider", "postmenopausal women", "bone mineral density", "Administration Dosage", "esophageal irritation", "monthly dosing regimen", "non-vertebral fractures", "individual patient needs", "frequent dosing schedules", "Convenient Monthly Dosing", "consistent dosing schedule", "potent bisphosphonate medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1664, "imageuri": "https://productimages.withfloats.com/actual/6666d20e0b4fc76a999ab2ab.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6666d20e0b4fc76a999ab2ab.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T10:14:35.368Z", "updatedon": "2026-03-14T07:08:59.352Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ibandzonic-150-/1664", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IBANDZONIC 150 ", "category": "ORTHOLOGYRANG", "tags": [ "IBANDZONIC 150 mg", "Ibandronate Sodium (150mg)", "", "ibandronate 150 mg tablet uses", "", "ibandronate 150 mg tablet price", "", "ibandronate 150 mg side effects", "", "ibandronate sodium injection" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "69e8bb02806295e2dbefc5e3", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "risedronate sodium tablets ip 35 mg", "description": "Risedronate Sodium Tablets IP 35 mg\n\nMaintaining strong and healthy bones becomes increasingly important with age, especially for individuals at risk of osteoporosis or bone loss. Risedronate Sodium Tablets IP 35 mg is a clinically proven medication widely prescribed to strengthen bones, reduce fracture risk, and improve overall skeletal health. If you are considering this treatment, this buyer-focused guide will help you understand everything—from how it works to its benefits, dosage, precautions, and what to check before purchasing.\n\nWhat are Risedronate Sodium Tablets IP 35 mg?\n\nRisedronate Sodium Tablets IP 35 mg contains risedronate sodium, a medication that belongs to a class called bisphosphonates. These drugs are specifically designed to prevent bone breakdown and increase bone density.\n\nIt is commonly used to treat and prevent the following:\n\nOsteoporosis in postmenopausal women\nOsteoporosis in men\nBone loss due to long-term steroid use\nPaget’s disease of bone\n\nThis once-weekly dosage (35 mg) is convenient and effective for long-term bone health management.\n\nHow Do Risedronate Sodium Tablets IP 35 mg Work?\n\nBones are constantly being renewed through a process called bone remodeling, where old bone is broken down and new bone is formed. In conditions like osteoporosis, bone breakdown occurs faster than formation, leading to weak and fragile bones.\n\nMechanism of Action:\nRisedronate inhibits osteoclasts (cells responsible for bone breakdown)\nSlows down bone loss\nHelps maintain or increase bone density\nReduces the risk of fractures, especially in the spine and hips\n\nBy restoring balance in bone remodeling, this medication strengthens bones over time.\n\nKey Benefits of Risedronate Sodium Tablets IP 35 mg\n1. Strengthens Bones\n\nHelps increase bone mineral density, making bones stronger and less prone to fractures.\n\n2. Reduces Fracture Risk\n\nSignificantly lowers the risk of spine, hip, and other bone fractures.\n\n3. Convenient Weekly Dosage\n\nThe 35 mg tablet is typically taken once a week, improving patient compliance.\n\n4. Effective for Long-Term Use\n\nSuitable for ongoing treatment under medical supervision.\n\n5. Proven Clinical Safety\n\nWidely used and trusted by healthcare professionals worldwide.\n\nWho Should Consider Buying Risedronate Sodium Tablets IP 35 mg?\n\nThis medication is suitable for:\n\nPostmenopausal women at risk of osteoporosis\nMen diagnosed with low bone density\nPatients on long-term corticosteroid therapy\nIndividuals with a history of fractures due to weak bones\nPatients diagnosed with Paget’s disease\n\nImportant: Always consult a healthcare professional before starting this medication.\n\nDosage and Administration\n\nProper usage is crucial to ensure effectiveness and reduce side effects.\n\nGeneral Guidelines:\nUsually taken once weekly (same day each week)\nTake the tablet first thing in the morning\nSwallow with a full glass of plain water (not juice or milk)\nTake on an empty stomach\nImportant Instructions:\nDo not lie down for at least 30 minutes after taking the tablet\nAvoid eating or drinking anything else for 30 minutes\nDo not crush or chew the tablet\n\nFollowing these instructions helps prevent irritation of the esophagus and improves absorption.\n\nPossible Side Effects\n\nLike all medications, Risedronate Sodium Tablets IP 35 mg may cause side effects.\n\nCommon Side Effects:\nStomach pain\nIndigestion\nNausea\nJoint or muscle pain\nLess Common but Serious Side Effects:\nDifficulty swallowing\nSevere chest pain\nJaw pain (rare, associated with osteonecrosis)\nUnusual thigh bone fractures (rare)\n\nIf you experience severe or persistent symptoms, seek medical attention immediately.\n\nPrecautions and Warnings\n\nBefore using this medication, consider the following:\n\nMedical Conditions:\nInform your doctor if you have esophageal disorders\nPatients with kidney problems should use caution\nLow calcium levels should be corrected before starting treatment\nPregnancy and Breastfeeding:\nNot recommended unless prescribed\nConsult your doctor for guidance\nDrug Interactions:\n\nRisedronate may interact with the following:\n\nCalcium supplements\nAntacids\nIron supplements\n\nThese should be taken at a different time of day to avoid interference with absorption.\n\nStorage Instructions\n\nTo maintain the quality of the medication:\n\nStore in a cool, dry place\nKeep away from moisture and sunlight\nMaintain temperature below 25°C\nKeep out of reach of children\nBuying Guide: What to Check Before Purchase\n\nWhen purchasing Risedronate Sodium Tablets IP 35 mg, ensure the following:\n\nIt is prescribed by a qualified doctor\nThe product is from a reputable pharmaceutical brand\nPackaging is intact and properly sealed\nExpiry date is valid\nPurchased from a licensed pharmacy\n\nBulk buyers and distributors should source from trusted suppliers to ensure consistent quality and authenticity.\n\nWhy Choose Risedronate Sodium Tablets IP 35 mg?\n\nThis medication stands out due to:\n\nProven effectiveness in improving bone health\nConvenient once-weekly dosing\nReduced risk of fractures\nLong-term safety when monitored\nCost-effective treatment option\n\nFor individuals seeking reliable osteoporosis management, this tablet offers a practical and effective solution.\n\nFrequently Asked Questions (FAQs)\n1. How long does it take to see results?\n\nBone improvement may take several months, but fracture risk reduction begins earlier.\n\n2. Can I take it daily?\n\nNo, the 35 mg dose is typically taken once weekly.\n\n3. Is it safe for long-term use?\n\nYes, under medical supervision with regular monitoring.\n\n4. Can I take it with food?\n\nNo, it should be taken on an empty stomach for proper absorption.\n\n5. Do I need supplements with this medication?\n\nDoctors often recommend calcium and vitamin D supplements alongside treatment.\n\nLifestyle Tips for Better Bone Health\n\nTo maximize the benefits of Risedronate Sodium Tablets IP 35 mg:\n\nMaintain a calcium-rich diet\nEnsure adequate vitamin D intake\nEngage in weight-bearing exercises\nAvoid smoking and excessive alcohol consumption\nGet regular bone density tests\nConclusion\n\nRisedronate Sodium Tablets IP 35 mg is a trusted and effective solution for managing osteoporosis and improving bone strength. With its proven ability to reduce fracture risk and enhance bone density, it plays a vital role in long-term skeletal health.\n\nFor best results, follow your doctor’s instructions carefully, maintain a healthy lifestyle, and ensure regular medical check-ups. Choosing the right treatment today can significantly improve your bone health and overall quality of life in the future.", "price": 421.0, "discountamount": 127.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2387, "imageuri": "https://productimages.withfloats.com/actual/69e8bb084671736d8a47c29c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69e8bb084671736d8a47c29c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-22T12:11:46.043Z", "updatedon": "2026-04-23T06:25:36.613Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//risedronate-sodium-tablets-ip-35-mg/2387", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RISONDROS 35", "category": "ORTHOLOGYRANG", "tags": [ "risedronate sodium tablets ip 35 mg", "risedronate sodium tablets ip 35 mg uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "699990a8814d89cb6a29a9c8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ferric carboxymaltose injection", "description": "RUDIX FCM IV is a sterile intravenous iron formulation containing Ferric carboxymaltose, designed for the rapid and effective treatment of iron deficiency and iron deficiency anemia (IDA). It is specifically developed for patients who require fast iron replenishment, cannot tolerate oral iron supplements, or have conditions where oral iron therapy is ineffective.\n\nIron deficiency remains one of the most common nutritional deficiencies worldwide, affecting women, children, patients with chronic diseases, and individuals recovering from surgery. RUDIX FCM IV provides a modern, safe, and convenient approach to restoring iron stores efficiently under medical supervision.\n\nProduct Overview\n\nProduct Name: RUDIX FCM IV\n\nGeneric Name: Ferric Carboxymaltose Injection\n\nDosage Form: Intravenous injection / infusion\n\nRoute of Administration: IV use only\n\nIndication: Treatment of iron deficiency and iron deficiency anemia\n\nRUDIX FCM IV is formulated using advanced iron-carbohydrate complex technology that allows controlled and gradual release of iron into the bloodstream. This reduces the risk of free iron toxicity while ensuring effective replenishment of hemoglobin levels and iron stores.\n\nWhat is Ferric Carboxymaltose?\n\nFerric carboxymaltose is a next-generation intravenous iron complex. Unlike traditional iron salts, it allows the administration of larger single doses in a shorter duration, reducing the need for multiple hospital visits. The iron core is tightly bound within a carbohydrate shell, enabling controlled release and minimizing adverse reactions compared to older IV iron formulations.\n\nOnce administered, iron from ferric carboxymaltose is taken up by the body's iron-binding proteins and transported to the bone marrow, where it supports red blood cell production and improves hemoglobin levels.\n\nUses of RUDIX FCM IV\n\nRUDIX FCM IV is indicated in the following medical conditions:\n\n1. Iron Deficiency Anemia (IDA)\n\nUsed when oral iron therapy is ineffective, poorly tolerated, or when rapid correction of anemia is required.\n\n2. Chronic Kidney Disease (CKD)\n\nPatients with CKD often experience anemia due to reduced erythropoietin production and iron deficiency. IV iron helps restore iron levels efficiently.\n\n3. Postpartum Anemia\n\nWomen who experience significant blood loss during childbirth may require quick iron restoration.\n\n4. Heavy Menstrual Bleeding\n\nFor women with chronic blood loss leading to iron deficiency.\n\n5. Gastrointestinal Disorders\n\nConditions such as inflammatory bowel disease (IBD), celiac disease, or gastric surgery can impair iron absorption, making IV iron therapy necessary.\n\n6. Pre- and Post-Surgical Patients\n\nPatients undergoing major surgeries may require rapid iron replenishment to improve recovery.\n\nKey Benefits of RUDIX FCM IV\n✔ Rapid Iron Replenishment\n\nAllows administration of high doses in a single sitting, helping patients recover faster compared to oral supplements.\n\n✔ Improved Patient Compliance\n\nFewer hospital visits are required due to the ability to deliver larger doses in one infusion.\n\n✔ Better Tolerability\n\nLower incidence of gastrointestinal side effects compared to oral iron therapy.\n\n✔ Controlled Iron Release\n\nThe stable iron-carbohydrate complex reduces the risk of free iron reactions.\n\n✔ Suitable for Multiple Patient Groups\n\nSafe for use in adults with various underlying medical conditions under medical supervision.\n\n✔ Clinically Proven Effectiveness\n\nHelps improve hemoglobin levels, replenish iron stores, and reduce fatigue and weakness associated with anemia.\n\nDosage and Administration\n\nRUDIX FCM IV should be administered only by qualified healthcare professionals in a clinical setting. The dosage depends on:\n\nPatient’s body weight\n\nHemoglobin level\n\nSeverity of iron deficiency\n\nUnderlying medical condition\n\nIt may be given as a slow intravenous injection or diluted in saline for infusion. Monitoring during and after administration is recommended to ensure patient safety.\n\nPossible Side Effects\n\nLike all medications, RUDIX FCM IV may cause side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nHeadache\n\nNausea\n\nDizziness\n\nInjection site reactions\n\nFlushing\n\nLess Common but Serious Reactions:\n\nHypersensitivity reactions\n\nHypotension (low blood pressure)\n\nAllergic reactions\n\nShortness of breath\n\nPatients should be monitored during infusion. Immediate medical attention is required if signs of severe allergic reactions occur.\n\nPrecautions and Warnings\n\nShould not be used in patients with known hypersensitivity to ferric carboxymaltose.\n\nNot recommended in patients with iron overload disorders such as hemochromatosis.\n\nUse cautiously in patients with liver dysfunction.\n\nPregnancy and lactation use should be evaluated by a healthcare provider.\n\nMust be administered in facilities equipped to manage anaphylactic reactions.\n\nStorage Instructions\n\nStore at controlled room temperature.\n\nProtect from light.\n\nDo not freeze.\n\nKeep out of reach of children.\n\nWhy Choose RUDIX FCM IV?\nRUDIX FCM IV stands out due to its high-quality formulation, safety profile, and effectiveness in treating iron deficiency anemia. It offers healthcare providers a reliable option for rapid correction of iron deficiency while minimizing patient inconvenience.\n\nIts ability to deliver higher doses in fewer sessions makes it a preferred choice in hospitals, nephrology clinics, gynecology practices, and surgical recovery units.\nConclusion\nIron deficiency anemia can significantly impact quality of life, causing fatigue, weakness, reduced immunity, and impaired cognitive function. Timely correction is essential to restore overall health and vitality.", "price": 2050.0, "discountamount": 615.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2310, "imageuri": "https://productimages.withfloats.com/actual/699990ae4601efddb00d005a.png", "tileimageuri": "https://productimages.withfloats.com/tile/699990ae4601efddb00d005a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-21T11:02:00.008Z", "updatedon": "2026-05-27T10:36:01.116Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ferric-carboxymaltose-injection/2310", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RUDIX FCM IV", "category": "GYANECOLOGYRANGE", "tags": [ "ferric carboxymaltose injection 1000mg IV for anemia", "ferric carboxymaltose IV iron therapy dosage guide", "ferric carboxymaltose injection for iron deficiency anemia", "buy ferric carboxymaltose injection online", "ferric carboxymaltose IV injection price per vial", "ferric carboxymaltose injection 50 mg price", "ferric carboxymaltose injection price", "ferric carboxymaltose injection uses in hindi", "ferric carboxymaltose injection uses in hindi", "what is ferric carboxymaltose injection", "what is ferric carboxymaltose injection used for", "Ferric carboxymaltose injection" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "696ddf1a8f7ed3c5c7df9f01", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Eltrombopag Olamine Tablets 50 mg", "description": "Eltrombopag Olamine Tablets 50 mg, marketed under the brand name LTROLAMINE 50, is a prescription medicine widely used in the management of low platelet count (thrombocytopenia) associated with certain blood disorders. It belongs to a class of medicines known as thrombopoietin receptor agonists, which work by stimulating platelet production in the bone marrow.\n\nLTROLAMINE 50 has become an important therapeutic option for patients who struggle with chronic platelet deficiency and are at increased risk of bleeding. With proven efficacy and a well-defined mechanism of action, this medication plays a crucial role in improving patient outcomes and quality of life.\n\nWhat is Eltrombopag Olamine Tablets 50 mg?\n\nEltrombopag Olamine Tablets 50 mg is an oral medication designed to increase platelet counts in patients whose body does not produce enough platelets naturally. Platelets are essential blood components responsible for clot formation and prevention of excessive bleeding.\n\nLTROLAMINE 50 is commonly prescribed for:\n\nChronic Immune Thrombocytopenia (ITP)\n\nSevere Aplastic Anemia\n\nThrombocytopenia associated with chronic Hepatitis C infection (in specific cases)\n\nBy improving platelet levels, LTROLAMINE 50 helps reduce bleeding risks and supports safer daily functioning for patients.\n\nUses of LTROLAMINE 50\n\nLTROLAMINE 50 is primarily used in the treatment of conditions characterized by low platelet counts, including:\n\n1. Chronic Immune Thrombocytopenia (ITP)\n\nIn patients with ITP, the immune system mistakenly destroys platelets. LTROLAMINE 50 stimulates platelet production, helping maintain a safer platelet count and lowering the risk of spontaneous bleeding.\n\n2. Severe Aplastic Anemia\n\nIn aplastic anemia, the bone marrow fails to produce sufficient blood cells. Eltrombopag Olamine supports bone marrow activity, leading to improved platelet and blood cell production when other treatments are ineffective.\n\n3. Hepatitis C–Associated Thrombocytopenia\n\nSome patients with chronic Hepatitis C experience low platelet counts that limit antiviral therapy. LTROLAMINE 50 may be used to raise platelet levels, enabling continuation of essential treatment under medical supervision.\n\nHow LTROLAMINE 50 Works\n\nEltrombopag Olamine acts as a thrombopoietin receptor agonist. It binds to and activates the thrombopoietin (TPO) receptor found on bone marrow cells. This activation triggers a signaling process that stimulates the production of megakaryocytes—the cells responsible for forming platelets.\n\nUnlike platelet transfusions, which provide a temporary solution, LTROLAMINE 50 encourages the body to produce its own platelets, offering a more sustainable approach to managing thrombocytopenia.\n\nKey Benefits of LTROLAMINE 50\n\nLTROLAMINE 50 offers several clinically significant benefits:\n\n1. Increases Platelet Count Naturally\n\nBy stimulating bone marrow activity, LTROLAMINE 50 helps raise platelet levels without relying on transfusions.\n\n2. Reduces Bleeding Risk\n\nMaintaining adequate platelet counts significantly lowers the risk of bruising, nosebleeds, gum bleeding, and internal bleeding.\n\n3. Oral and Convenient Therapy\n\nAs an oral tablet, LTROLAMINE 50 is easy to administer and more comfortable for long-term use compared to injectable alternatives.\n\n4. Improves Quality of Life\n\nBy stabilizing platelet levels, patients can lead more active, confident lives with fewer hospital visits.\n\n5. Useful in Refractory Cases\n\nLTROLAMINE 50 is effective even in patients who do not respond adequately to first-line therapies like corticosteroids or immunoglobulins.\n\nDosage and Administration\n\nThe dosage of LTROLAMINE 50 is determined by the treating physician based on:\n\nPlatelet count\n\nUnderlying condition\n\nLiver function\n\nPatient response to therapy\n\nThe tablet is usually taken once daily, preferably on an empty stomach. Certain foods and supplements, especially those containing calcium, iron, magnesium, or aluminum, may interfere with absorption and should be avoided close to dosing time.\n\nPatients must strictly follow medical advice and undergo regular blood tests to monitor platelet levels and liver function.\n\nPossible Side Effects of LTROLAMINE 50\n\nLike all medicines, LTROLAMINE 50 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects\n\nHeadache\n\nNausea or vomiting\n\nFatigue\n\nDiarrhea\n\nMuscle or joint pain\n\nThese effects are generally mild and tend to improve as the body adjusts to the medication.\n\nLess Common but Serious Side Effects\n\nElevated liver enzymes\n\nRisk of blood clots if platelet counts become too high\n\nLiver function abnormalities\n\nCataract development with long-term use (rare)\n\nPatients should immediately inform their healthcare provider if they notice symptoms such as yellowing of the skin or eyes, severe abdominal pain, chest pain, or sudden swelling in limbs.\n\nPrecautions and Warnings\n\nLTROLAMINE 50 should only be used under strict medical supervision.\n\nRegular blood tests are essential to avoid excessive platelet increase.\n\nCaution is advised in patients with liver disease.\n\nPregnant or breastfeeding women should consult their doctor before use.\n\nThe medicine should not be stopped abruptly without medical advice.\n\nConclusion\n\nEltrombopag Olamine Tablets 50 mg (LTROLAMINE 50) is a clinically proven and effective therapy for managing thrombocytopenia associated with serious blood disorders. By stimulating the body’s natural platelet production, LTROLAMINE 50 helps reduce bleeding risk, minimize hospital dependence, and improve overall patient well-being.", "price": 1640.0, "discountamount": 492.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2279, "imageuri": "https://productimages.withfloats.com/actual/696ddf1b2b30597eb3c9bc2a.png", "tileimageuri": "https://productimages.withfloats.com/tile/696ddf1b2b30597eb3c9bc2a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-19T07:36:58.313Z", "updatedon": "2026-03-14T06:47:29.988Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//eltrombopag-olamine-tablets-50-mg/2279", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LTROLAMINE 50", "category": "GENERAL RANGE", "tags": [ "eltrombopag olamine tablets 50 mg", "eltrombopag 50 mg tablet uses", "eltrombopag olamine 50 mg tablets", "eltrombopag 50 mg dosage", "eltrombopag olamine tablet 50 mg price", "eltrombopag 50 mg tablet in India", "eltrombopag olamine tablets 50 mg for ITP", "eltrombopag 50 mg tablets for low platelet count", "eltrombopag olamine 50 mg tablets uses and benefits", "eltrombopag 50 mg tablet side effects", "how eltrombopag 50 mg works", "eltrombopag olamine tablets 50 mg mechanism of action", "eltrombopag 50 mg tablets for thrombocytopenia", "what is eltrombopag olamine 50 mg tablet", "eltrombopag 50 mg tablets indications", "eltrombopag olamine tablets 50 mg precautions", "eltrombopag 50 mg tablet dosage guidelines", "eltrombopag olamine tablets 50 mg safety profile", "buy eltrombopag olamine tablets 50 mg online", "eltrombopag 50 mg tablets wholesale supplier India", "eltrombopag olamine tablets 50 mg pharma company", "eltrombopag 50 mg tablets manufacturer in India", "eltrombopag olamine 50 mg tablets cost" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69623e6c95697555dd1afd67", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Esomeprazole and Itopride", "description": "ESMOSTRUM IT: Comprehensive Product Guide\nProduct Overview\nESMOSTRUM IT is an advanced pharmaceutical formulation that combines two potent active ingredients—Esomeprazole and Itopride—to provide comprehensive relief from gastrointestinal disorders. This dual-action medication represents a significant advancement in the management of acid-related digestive conditions and motility disorders. By combining a proton pump inhibitor with a prokinetic agent, ESMOSTRUM IT addresses both the underlying causes and symptomatic manifestations of various digestive ailments, offering patients a complete therapeutic solution in a single, convenient dosage form.\nThe synergistic combination of Esomeprazole and Itopride makes ESMOSTRUM IT particularly effective for individuals suffering from gastroesophageal reflux disease (GERD), functional dyspepsia, and other conditions where both excessive acid production and impaired gastric motility contribute to discomfort and disease progression.\nActive Pharmaceutical Ingredients\nEsomeprazole\nEsomeprazole is the S-isomer of omeprazole and belongs to the class of medications known as proton pump inhibitors (PPIs). It works by specifically and irreversibly blocking the hydrogen-potassium adenosine triphosphatase enzyme system (the proton pump) located in the gastric parietal cells. This mechanism effectively reduces gastric acid secretion, providing sustained relief from acid-related symptoms and allowing damaged esophageal and gastric tissue to heal.\nItopride\nItopride is a prokinetic agent that enhances gastrointestinal motility through a dual mechanism of action. It acts as both a dopamine D2 receptor antagonist and an acetylcholinesterase inhibitor. By blocking dopamine receptors, it removes the inhibitory effect of dopamine on gastrointestinal motility, while its acetylcholinesterase inhibition increases acetylcholine levels, further promoting coordinated gastric contractions and improved gastric emptying.\nTherapeutic Uses and Indications\nESMOSTRUM IT is prescribed for a wide range of gastrointestinal conditions where both acid suppression and enhanced motility are therapeutically beneficial:\nGastroesophageal Reflux Disease (GERD)\nESMOSTRUM IT provides exceptional relief for patients suffering from GERD, a chronic condition where stomach acid frequently flows back into the esophagus. The esomeprazole component reduces acid production, while itopride improves the tone of the lower esophageal sphincter and accelerates gastric emptying, thereby reducing the frequency and severity of reflux episodes.\nFunctional Dyspepsia\nFor patients experiencing persistent or recurrent upper abdominal discomfort without an identifiable organic cause, ESMOSTRUM IT addresses multiple pathophysiological mechanisms. It relieves symptoms such as early satiety, postprandial fullness, epigastric pain, and bloating by normalizing gastric acid levels and improving gastric accommodation and emptying.\nPeptic Ulcer Disease\nESMOSTRUM IT aids in the healing of gastric and duodenal ulcers by creating an optimal healing environment through sustained acid suppression. The prokinetic action of itopride helps prevent stasis of gastric contents, which can exacerbate ulcer symptoms.\nNon-Ulcer Dyspepsia\nMany patients experience dyspeptic symptoms without evidence of ulceration. ESMOSTRUM IT effectively manages these symptoms by addressing both acid hypersecretion and delayed gastric emptying, two key factors in non-ulcer dyspepsia.\nGastroparesis-Related Symptoms\nIn conditions where gastric emptying is significantly delayed, the itopride component of ESMOSTRUM IT helps restore more normal gastric motility patterns, reducing associated symptoms like nausea, vomiting, and abdominal distension.\nKey Benefits and Advantages\nDual Mechanism of Action\nThe primary advantage of ESMOSTRUM IT lies in its comprehensive approach to gastrointestinal health. Rather than addressing only acid production or motility in isolation, this combination therapy tackles both aspects simultaneously, providing more complete symptom relief and better therapeutic outcomes.\nSuperior Acid Suppression\nEsomeprazole offers more consistent and prolonged acid suppression compared to many other acid-reducing medications. It provides sustained relief throughout the day and night, allowing patients to experience fewer breakthrough symptoms and better quality of life.\nEnhanced Gastric Motility\nThe itopride component specifically targets motility issues without crossing the blood-brain barrier significantly, meaning it provides prokinetic benefits with minimal central nervous system side effects. This results in improved gastric emptying, reduced bloating, and decreased feelings of fullness after meals.\nRapid Symptom Relief\nMany patients experience noticeable improvement in their symptoms within the first few days of treatment with ESMOSTRUM IT. The combination therapy addresses multiple symptom pathways simultaneously, leading to faster and more comprehensive relief.\nImproved Quality of Life\nBy effectively managing symptoms such as heartburn, regurgitation, nausea, bloating, and early satiety, ESMOSTRUM IT significantly enhances patients' daily functioning and overall well-being. Patients report better sleep quality, improved dietary tolerance, and reduced anxiety related to their digestive symptoms.\nConvenient Dosing\nThe combination of two active ingredients in a single formulation improves medication adherence by reducing pill burden. Patients appreciate the simplicity of taking one medication instead of multiple separate preparations.\nMucosal Healing Properties\nBeyond symptom relief, ESMOSTRUM IT promotes actual healing of damaged esophageal and gastric mucosa. The reduced acid environment created by esomeprazole allows inflamed and eroded tissue to regenerate properly.\nReduced Risk of Complications\nBy effectively controlling acid reflux and improving gastric emptying, ESMOSTRUM IT helps prevent potential complications of chronic GERD, such as esophageal strictures, Barrett's esophagus, and respiratory complications from aspiration.\nDosage and Administration\nESMOSTRUM IT should be taken exactly as prescribed by a healthcare professional. Typically, the medication is administered orally, preferably before meals to optimize its therapeutic effects. The standard dosing regimen usually involves once or twice daily administration, though individual requirements may vary based on the severity of the condition and patient response.\nThe medication should be swallowed whole with water and should not be crushed, chewed, or split, as this may affect the drug's release mechanism and therapeutic efficacy. Patients should maintain regular dosing schedules to ensure optimal acid suppression and motility enhancement throughout the day.\nSide Effects and Safety Considerations\nLike all medications, ESMOSTRUM IT may cause side effects in some individuals, though not everyone experiences them. Understanding potential adverse effects helps patients identify and report concerning symptoms promptly.\nCommon Side Effects\nGastrointestinal Effects: Some patients may experience diarrhea, constipation, abdominal pain, nausea, or flatulence, particularly during initial treatment. These effects are usually mild and often resolve as the body adjusts to the medication.\nHeadache: Mild to moderate headaches occur in a small percentage of patients and typically diminish with continued use.\nDizziness: Some individuals may experience lightheadedness or dizziness, particularly when standing up quickly.\nDry Mouth: Reduced saliva production may occur, leading to oral dryness and discomfort.\nLess Common Side Effects\nSkin Reactions: Rash, itching, or other dermatological manifestations may develop in sensitive individuals.\nSleep Disturbances: Some patients report insomnia or unusual dreams while taking the medication.\nIncreased Prolactin Levels: Itopride may cause mild elevation in prolactin levels, though clinical manifestations are rare.\nTaste Alterations: Changes in taste perception or metallic taste may occur temporarily.\nSerious Side Effects (Rare)\nWhile uncommon, certain serious adverse effects require immediate medical attention:\n\nSevere allergic reactions including difficulty breathing, facial swelling, or severe skin reactions\nSevere diarrhea that persists or contains blood\nIrregular heartbeat or palpitations\nMuscle weakness or pain\nSeizures or tremors\nSigns of liver problems including jaundice, dark urine, or persistent nausea\n\nLong-Term Considerations\nExtended use of proton pump inhibitors like esomeprazole has been associated with certain risks that patients should discuss with their healthcare providers:\n\nPotential reduction in calcium, magnesium, and vitamin B12 absorption\nSlightly increased risk of bone fractures with prolonged use\nPossible increased susceptibility to certain gastrointestinal infections\nRare cases of kidney problems\n\nRegular monitoring and periodic assessment by healthcare professionals help minimize these risks while maintaining therapeutic benefits.\nPrecautions and Contraindications\nPatients should inform their healthcare provider about all existing medical conditions, particularly liver disease, kidney problems, osteoporosis, low magnesium levels, or any gastrointestinal bleeding. ESMOSTRUM IT may interact with certain medications, including blood thinners, antifungals, HIV medications, and certain antibiotics. A complete medication review ensures safe and effective therapy.\nPregnant or breastfeeding women should only use ESMOSTRUM IT under strict medical supervision, as the safety profile in these populations requires careful consideration of potential risks and benefits.\nLifestyle Recommendations\nFor optimal therapeutic outcomes, patients taking ESMOSTRUM IT should complement their medication regimen with appropriate lifestyle modifications:\n\nAvoid trigger foods that exacerbate acid reflux, such as spicy foods, citrus, chocolate, caffeine, and alcohol\nMaintain a healthy body weight to reduce abdominal pressure\nEat smaller, more frequent meals rather than large portions\nAvoid lying down immediately after eating; wait at least two to three hours\nElevate the head of the bed if nighttime symptoms occur\nQuit smoking, as tobacco use significantly worsens reflux symptoms\nManage stress through relaxation techniques, as stress can exacerbate digestive symptoms\n\nConclusion\nESMOSTRUM IT represents a sophisticated and effective pharmaceutical solution for individuals struggling with complex gastrointestinal disorders involving both acid hypersecretion and impaired motility. By combining the powerful acid-suppressing capabilities of esomeprazole with the prokinetic benefits of itopride, this medication offers comprehensive symptom management that addresses the multifaceted nature of digestive disorders.", "price": 182.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2273, "imageuri": "https://productimages.withfloats.com/actual/69623e6fd8491171373812e3.png", "tileimageuri": "https://productimages.withfloats.com/tile/69623e6fd8491171373812e3.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-10T11:56:28.061Z", "updatedon": "2026-04-21T09:38:56.999Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//esomeprazole-and-itopride/2273", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ESMOSTRUM IT", "category": "GASTROLOGYRANGE", "tags": [ "esomeprazole and itopride", "esomeprazole and itopride capsules uses in hindi", "esomeprazole and itopride capsules uses", "esomeprazole and itopride brand name", "esomeprazole and itopride hydrochloride", "esomeprazole and itopride capsules", "esomeprazole and itopride uses", "esomeprazole and itopride hydrochloride capsules", "esomeprazole and itopride hydrochloride uses", "esomeprazole and itopride hydrochloride price", "esomeprazole and itopride hydrochloride price in india", "buy online Esomeprazole and Itopride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "695b65af2800555f6696a6cf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cinacalcet 60 mg Tablet", "description": "CINASELECT 60: Comprehensive Guide to Cinacalcet 60 mg Tablets\nProduct Overview\nCINASELECT 60 is a pharmaceutical formulation containing Cinacalcet hydrochloride 60 mg as its active ingredient. This medication represents a significant advancement in the management of calcium metabolism disorders, particularly in patients with chronic kidney disease and parathyroid conditions. As a calcimimetic agent, CINASELECT 60 works by mimicking the action of calcium on tissues, helping to restore hormonal balance and mineral homeostasis in the body.\nThe 60 mg dosage strength offers an effective therapeutic option for patients requiring moderate to higher-level intervention in managing parathyroid hormone levels and associated calcium imbalances. CINASELECT 60 is manufactured under strict quality control standards, ensuring consistency, purity, and efficacy in every tablet.\nUnderstanding How CINASELECT 60 Works\nCINASELECT 60 operates through a sophisticated mechanism that targets the calcium-sensing receptors located on the surface of parathyroid gland cells. These receptors play a crucial role in regulating parathyroid hormone secretion, which in turn controls calcium and phosphorus levels in the bloodstream.\nWhen you take CINASELECT 60, the active ingredient cinacalcet binds to these calcium-sensing receptors, increasing their sensitivity to extracellular calcium. This enhanced sensitivity tricks the parathyroid glands into “thinking” there is more calcium present in the blood than there actually is. As a result, the glands reduce their production and release of parathyroid hormone (PTH).\nBy lowering PTH levels, CINASELECT 60 subsequently reduces calcium levels in the blood and decreases the amount of phosphorus absorbed from the intestines. This cascade effect helps restore the delicate mineral balance that is often disrupted in patients with kidney disease or parathyroid disorders.\nPrimary Therapeutic Uses\nSecondary Hyperparathyroidism in Chronic Kidney Disease\nThe primary indication for CINASELECT 60 is the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) who are on dialysis. When kidneys fail to function properly, they cannot adequately regulate calcium and phosphorus levels, leading to excessive parathyroid hormone production. This condition can result in serious complications including bone disease, cardiovascular calcification, and increased mortality risk.\nCINASELECT 60 helps manage this condition by controlling PTH levels, thereby reducing the risk of bone complications such as osteitis fibrosa cystica and preventing the dangerous deposition of calcium in blood vessels and soft tissues.\nHypercalcemia in Parathyroid Carcinoma\nCINASELECT 60 is also indicated for treating hypercalcemia (elevated blood calcium levels) in patients with parathyroid carcinoma, a rare malignant tumor of the parathyroid glands. In these cases, the medication helps control the dangerously high calcium levels that can lead to kidney stones, bone pain, digestive issues, and neurological symptoms.\nPrimary Hyperparathyroidism\nFor patients with severe hypercalcemia due to primary hyperparathyroidism who cannot undergo parathyroidectomy or for whom surgery has failed, CINASELECT 60 offers a valuable medical management option. This provides relief for patients who are not surgical candidates due to advanced age, comorbidities, or other contraindications.\nKey Benefits of CINASELECT 60\nEffective PTH Control\nClinical studies have demonstrated that CINASELECT 60 significantly reduces parathyroid hormone levels in a dose-dependent manner. This reduction helps prevent the cascade of complications associated with elevated PTH, including bone mineral loss and cardiovascular calcification.\nImproved Calcium-Phosphorus Balance\nBy reducing PTH secretion, CINASELECT 60 helps normalize serum calcium and phosphorus levels. This is particularly important in dialysis patients, where mineral imbalances can lead to serious complications affecting bone health, cardiovascular function, and overall quality of life.\nReduced Cardiovascular Risk\nElevated calcium and phosphorus levels contribute to vascular calcification, a major risk factor for cardiovascular disease in patients with chronic kidney disease. By managing these mineral levels, CINASELECT 60 may help reduce the risk of cardiovascular complications, which are the leading cause of death in dialysis patients.\nBone Health Preservation\nUncontrolled secondary hyperparathyroidism leads to renal osteodystrophy, a condition characterized by abnormal bone metabolism. CINASELECT 60 helps protect bone integrity by normalizing PTH levels, potentially reducing fracture risk and preserving bone mineral density.\nAlternative to Surgery\nFor patients with primary hyperparathyroidism or parathyroid carcinoma who cannot undergo surgery, CINASELECT 60 provides an effective medical management option. This is particularly valuable for elderly patients or those with multiple comorbidities that make surgery risky.\nQuality of Life Improvement\nBy controlling symptoms associated with hypercalcemia and hyperparathyroidism, such as bone pain, muscle weakness, fatigue, and digestive issues, CINASELECT 60 can significantly improve patients' overall quality of life and functional capacity.\nConvenient Oral Administration\nCINASELECT 60 is administered orally, making it more convenient than injectable alternatives. This allows for outpatient management and reduces the burden on healthcare facilities and patients.\nPotential Side Effects and Adverse Reactions\nCommon Side Effects\nPatients taking CINASELECT 60 may experience several common side effects, which typically include nausea and vomiting, occurring in approximately 20-30% of patients. These gastrointestinal symptoms are usually mild to moderate and may improve over time as the body adjusts to the medication.\nDiarrhea is another frequent complaint, affecting roughly 20% of users. Some patients also report muscle pain or myalgia, dizziness, loss of appetite, and asthenia (general weakness or fatigue).\nSerious Side Effects Requiring Medical Attention\nHypocalcemia: The most significant risk associated with CINASELECT 60 is the development of low calcium levels in the blood. Severe hypocalcemia can lead to paresthesias (tingling sensations), muscle cramps or spasms, tetany, seizures, and QT interval prolongation on electrocardiogram, which can predispose to dangerous heart rhythm abnormalities.\nGastrointestinal Bleeding: There have been reports of gastrointestinal hemorrhage in patients taking cinacalcet, particularly in those with risk factors such as gastritis, ulcers, or concurrent use of other medications that increase bleeding risk.\nAdynamic Bone Disease: Oversuppression of PTH can lead to adynamic bone disease, a condition where bone turnover becomes abnormally low, potentially weakening bones despite normalized calcium levels.\nCardiovascular Effects: Some patients may experience worsening heart failure or arrhythmias, particularly if hypocalcemia develops. Close monitoring is essential in patients with underlying cardiovascular disease.\nAllergic Reactions: Though rare, hypersensitivity reactions including rash, urticaria, and angioedema have been reported.\nPrecautions and Contraindications\nCINASELECT 60 should not be used in patients with serum calcium levels below the normal range. It requires careful dose adjustment and monitoring in patients with hepatic impairment. The medication may interact with drugs metabolized by the CYP2D6 enzyme system and with medications that affect gastric pH.\nPregnant or breastfeeding women should use CINASELECT 60 only if clearly needed, as its safety in these populations has not been fully established. Regular monitoring of serum calcium, phosphorus, and PTH levels is essential throughout treatment.\nDosage and Administration Guidelines\nCINASELECT 60 should be taken orally with food or shortly after a meal, as this improves absorption and reduces gastrointestinal side effects. Tablets should be swallowed whole and not crushed, chewed, or divided.\nThe typical starting dose for secondary hyperparathyroidism is lower than 60 mg, with gradual titration based on PTH and calcium levels. The 60 mg strength is often used as part of the dose escalation process or as a maintenance dose once optimal PTH control is achieved.\nDose adjustments should be made no more frequently than every two to four weeks, as it takes this long to see the full effect of a dose change on PTH levels. Treatment should be individualized based on laboratory values and clinical response.\nMonitoring Requirements\nPatients on CINASELECT 60 require regular monitoring of serum calcium, phosphorus, and intact PTH levels. Calcium levels should be checked within one week of starting treatment or after any dose adjustment, and then monthly once stable. PTH levels should be measured one to four weeks after initiation or dose adjustment, then every one to three months during maintenance therapy.\nAdditionally, patients should be monitored for signs and symptoms of hypocalcemia, particularly during the initial treatment period. Electrocardiogram monitoring may be appropriate in patients at risk for QT prolongation.\nStorage and Handling\nCINASELECT 60 should be stored at room temperature, away from moisture and direct sunlight. The medication should be kept in its original container with the lid tightly closed to protect from humidity. Keep out of reach of children and pets. Do not use past the expiration date printed on the package.\nConclusion\nCINASELECT 60 (Cinacalcet 60 mg) represents a valuable therapeutic option in the management of secondary hyperparathyroidism associated with chronic kidney disease, hypercalcemia in parathyroid carcinoma, and primary hyperparathyroidism in patients who cannot undergo surgery. Its unique mechanism as a calcimimetic agent provides effective control of parathyroid hormone secretion, helping to restore mineral balance and prevent serious complications.\nThe benefits of CINASELECT 60 extend beyond simple laboratory value normalization. By controlling PTH, calcium, and phosphorus levels, this medication helps preserve bone health, reduce cardiovascular calcification risk, and improve overall quality of life for patients dealing with complex metabolic disorders. For patients who are not surgical candidates, CINASELECT 60 offers hope and effective symptom management.\nHowever, like all medications, CINASELECT 60 must be used judiciously under close medical supervision. The risk of hypocalcemia and other potential side effects necessitates regular laboratory monitoring and open communication between patients and healthcare providers. Patients should report any concerning symptoms promptly and attend all scheduled follow-up appointments.", "price": 740.0, "discountamount": 222.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2266, "imageuri": "https://productimages.withfloats.com/actual/695b65ebf30763183f64d4f7.png", "tileimageuri": "https://productimages.withfloats.com/tile/695b65ebf30763183f64d4f7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-05T07:18:07.264Z", "updatedon": "2026-05-01T06:30:26.075Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cinacalcet-60-mg-tablet/2266", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CINASELECT 60", "category": "NEPHROLOGYRANGE", "tags": [ "cinacalcet 60 mg", "cinacalcet mechanism of action.", "cinacalcet uses", "tab cinacalcet.", "cinacalcet dose.", "cinacalcet structure.", "cinacalcet tab.", "calcium and phosphorus levels in the bloodstream.", "parathyroid hormone secretion.", "calcium metabolism disorders.", "chronic kidney disease and parathyroid conditions.", "cinacalcet 60 mg", "cinacalcet 60", "Cinacalcet Tablets 60 mg price in India", "Buy Cinacalcet Tablets 60 mg online", "Cinacalcet 60 mg wholesale price", "Buy Cinacalcet Tablets 60 mg", "Get Cinacalcet Tablets 60 mg at best price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948f4ee5837f90c86a7e578", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Elagolix 200mg ", "description": "Eligolux200 contains 200 mg of elagolix per tablet and is manufactured by Steris Healthcare Pvt Ltd in India as a prescription medication in packs of 3x10 tablets. Elagolix acts as a potent gonadotropin-releasing hormone (GnRH) receptor antagonist, binding competitively to GnRH receptors in the pituitary gland to rapidly reduce estrogen and progesterone levels without the initial flare-\nup seen in agonists. This mechanism starves endometrial-like tissue outside the uterus of hormonal stimulation, shrinking lesions and easing inflammation.\n\nAdminister Eligolux200 orally, swallowed whole with water, with or without food, typically starting within 7 days of menstrual onset. Standard dosing for severe cases involves 200mg twice daily for up to 6 months, or 150mg once daily extended to 24 months, adjusted by physicians based on tolerance and response. Store in a cool, dry place away from moisture and light, keeping out of children's reach.\n\nPrimary Uses\nEligolux200 targets moderate to severe endometriosis-associated pain, including dysmenorrhea (painful periods), nonmenstrual pelvic pain, and dyspareunia (painful intercourse). Endometriosis affects millions globally, causing tissue similar to the uterine lining to grow ectopically, leading to chronic inflammation, adhesions, and scarring. By dosing flexibly, Eligolux200 suits patients needing stronger suppression for intense symptoms, reducing reliance on opioids or surgery.\n\nClinical trials like Elaris EM-I and EM-II showed 75% dysmenorrhea reduction and 50-60% nonmenstrual pain relief at 6-12 months. It also curbs heavy menstrual bleeding in uterine fibroids, offering dual benefits for overlapping conditions. Physicians prescribe it when first-line NSAIDs or oral contraceptives fail, prioritizing non-invasive symptom control.\n​\n\nKey Benefits\nEligolix in Eligolux200 delivers rapid pain relief, with significant improvements in daily pain scales within 3 months versus placebo. Women report 47% better composite pelvic pain scores, enhancing daily activities, work productivity, and intimacy. Quality-of-life metrics improve consistently over 24 weeks, including reduced fatigue and better emotional well-being.\n​\n\nUnlike injectables, its oral form and dose-dependent estrogen suppression allow titration—lower doses minimize hypoestrogenic effects while higher 200mg dosing tackles severe pain. Studies confirm amenorrhea in 25% of users early on, slashing bleeding days by up to 50%. Long-term data up to 12 months with add-back therapy sustains efficacy, preserving bone health better than monotherapy. Patients regain control, avoiding invasive laparoscopies and reclaiming normalcy.\n​\n\nBenefit\tEvidence from Trials'\tImpact on Patients\nDysmenorrhea Reduction:\t75% at 6 months \n​\tFewer missed workdays\nNonmenstrual Pain Relief:\t50-60% improvement \n​\tEnhanced mobility\nBleeding Control:\t14% bleeding days vs. 24% baseline \n​\tImproved hygiene, anemia prevention\nQuality of Life\tSustained over 24 weeks \n​\tBetter sleep, relationships\nPotential Side Effects\nCommon side effects of Eligolux200 mirror hypoestrogenic states: hot flashes, night sweats, headache, and nausea, each affecting about 10% of users. These often lessen as the body adjusts, with 69.5% overall adverse event rate over 24 weeks, mostly mild. Mood changes like irritability or depression occur less commonly, warranting mood monitoring.\n​\n\nBone mineral density (BMD) loss poses a key concern—200mg twice daily causes -1.5% to -2.4% drops at lumbar spine and hip after 6 months, attenuated with calcium/vitamin D or add-back therapy. Rare serious risks include suicidal thoughts, liver enzyme elevations, or allergic reactions like anaphylaxis. Discontinuation due to events stays low at 4-12%. No deaths are linked directly to treatment in trials.\n​\n\nSide Effect Category\tFrequency\tManagement\nVasomotor (Hot Flashes)\t9.9-10% \n​\tLifestyle cooling, dose adjustment\nNeurologic (Headache)\t9.9% \n​\tHydration, analgesics\nBone Loss\tUp to 2.4% at 6 months \n​\tDEXA scans, supplements\nMood Changes\tLess common \n​\tPsychiatric screening\nPrecautions and Contraindications\nAvoid Eligolux200 in pregnancy (risk of early loss), known osteoporosis, severe hepatic impairment, or with strong OATP1B1 inhibitors like cyclosporine or gemfibrozil. Women of childbearing age need effective non-hormonal contraception during and 28 days post-therapy, as it impairs recognition of pregnancy via amenorrhea. Not for pediatrics under 18 or geriatrics lacking data.\n\nScreen for depression history, liver function, and BMD before starting; monitor quarterly. Drug interactions abound with rifampin (reduces levels) or over 50 others like clarithromycin—inform physicians fully. Breastfeeding lacks safety data; weigh risks. Regular blood/urine tests track efficacy and safety.\n​\n\nDosage Guidelines\nInitiate Eligolux200 at 150mg daily for milder cases, escalating to 200mg BID for dyspareunia or severe pain, max 6 months at higher dose. Miss a dose? Take promptly unless near the next; never double. Duration caps at 24 months total, with liver-adjusted lower dosing. Pair with add-back for extended use to curb BMD loss.\n​\n\nPhysicians tailor based on response: 74-77% complete 6-month trials. Swallow intact; no crushing.\n​\n\nClinical Evidence\nPhase III trials (Elaris EM-I/II) randomized 1689 women, proving both doses superior to placebo for co-primary endpoints of dysmenorrhea and nonmenstrual pain. Open-label extensions to 24 weeks maintained gains. A 12-month study with add-back showed persistent relief and <1% additional BMD loss versus placebo. Real-world use echoes this, positioning Eligolix as first oral GnRH antagonist approved for endometriosis.\n​\n\nVersus relugolix, Eligolix offers comparable pelvic pain reduction with adjustable dosing. Indian brands like Eligolux200 align with global standards.\n​\n\nConclusion\nEligolux200 transforms endometriosis management, delivering substantial pain relief and functional gains through precise hormonal control. Balancing robust benefits against manageable risks like BMD monitoring empowers women toward symptom-free lives. Consult healthcare providers for personalized integration into care plans.\n", "price": 1000.0, "discountamount": 300.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2251, "imageuri": "https://productimages.withfloats.com/actual/694a2b9f403179ac7e958ef6.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2b9f403179ac7e958ef6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T07:36:14.316Z", "updatedon": "2026-03-26T06:00:31.59Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//elagolix-200mg-/2251", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 200", "category": "GYANECOLOGYRANGE", "tags": [ "Elagolix Tablets 200mg", "Elagolix acts as a potent gonadotropin-releasing hormone.", "nonmenstrual pelvic pain.", "adhesions, and scarring", "preserving bone health better than monotherapy.", "avoiding invasive laparoscopies and reclaiming normalcy.", "pituitary gland to rapidly reduce estrogen and progesterone.", "tab elagolix 200mg", "elagolix 200mg.", "elagolix.", "elagolix 200.", "elagolix tablets", "elagolix tablets uses.", "elagolix 200 mg price.", "elagolix mechanism of action.", "elagolix 200 mg uses.", "tab elagolixtab elagolix." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "692ab5ffce1207bc46287b8d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Undenatured Collagen Type II", "description": "Undenatured Collagen Type II (Collamy U2), Andrographis Paniculata Extract, Sodium Hyaluronate, Vitamin K2-7, and Vitamins combined in tablet form make a powerful supplement designed to enhance joint health, support cartilage regeneration, and improve overall mobility while providing essential nutrients that contribute to bone health and inflammation reduction.\n\nProduct Description and Uses\nThis multi-ingredient tablet harnesses the unique bioactive properties of undenatured collagen type II (Collamy U2), which plays a critical role in maintaining cartilage integrity and promoting its natural repair. Sodium Hyaluronate acts as a lubricant in the joints, enhancing smooth and pain-free movement. Andrographis Paniculata Extract adds anti-inflammatory and immune system support, while Vitamin K2-7 is essential for facilitating proper calcium utilization in bones, helping prevent calcification in soft tissues. Additional vitamins support overall joint, bone, and immune health. This supplement is commonly used for managing symptoms of osteoarthritis, joint stiffness, and mobility limitations caused by cartilage degradation or aging.\n\nKey Benefits Native type 2 collagen\nSupports cartilage regeneration and slows joint cartilage deterioration, improving joint function and reducing pain.\n\nEnhances lubrication and cushioning in joints through Sodium Hyaluronate, leading to increased flexibility and comfort during movement.\n\nCombats inflammation naturally with Andrographis Paniculata, helping to reduce joint swelling and discomfort.\n\nPromotes bone mineralization and strength with Vitamin K2-7, aiding calcium binding to the bone matrix and preventing calcium deposits in arteries.\n\nProvides antioxidant and immune system support via vitamins that contribute to overall musculoskeletal health.\n\nClinically, undenatured collagen type II has been associated with up to a 40% reduction in joint pain and significant improvement in joint mobility after regular use.\n\nSide Effects\nThis supplement is generally well tolerated. Some users might experience mild gastrointestinal discomfort, such as constipation or headaches, intermittently related to undenatured collagen type II. Andrographis Paniculata extract may occasionally cause mild digestive upset or allergic reactions in sensitive individuals. Since Vitamin K2-7 influences blood clotting pathways, caution is advised in people taking anticoagulant medications. No serious adverse effects have been commonly reported, making it a safe adjunct for joint health when used as directed.\n\nConclusion\nTablets combining Undenatured Collagen Type II (Collamy U2), Andrographis Paniculata Extract, Sodium Hyaluronate, Vitamin K2-7, and essential vitamins provide a comprehensive approach to joint care. By supporting cartilage repair, reducing inflammation, enhancing lubrication, and strengthening bones, this formulation offers significant benefits for those with joint discomfort or degenerative joint conditions. Its favorable safety profile and the synergy of active ingredients make it an effective supplement for maintaining joint health, mobility, and overall skeletal robustness.", "price": 578.0, "discountamount": 174.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2224, "imageuri": "https://productimages.withfloats.com/actual/692ab6019428a310247207ab.png", "tileimageuri": "https://productimages.withfloats.com/tile/692ab6019428a310247207ab.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-29T08:59:43.559Z", "updatedon": "2026-04-04T09:03:50.732Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//undenatured-collagen-type-ii/2224", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "COLLABOOST C2", "category": "ORTHOLOGYRANG", "tags": [ "Undenatured Collagen Type II", "Andrographis Paniculata Extract", "Sodium Hyaluronate", "Vitamin K2-7", "powerful supplement designed to enhance joint health.", "joint health.", "helping to reduce joint swelling and discomfort.", "strengthening bones.", "blood clotting pathways.", "UC-II collagen", "Type II collagen supplement", "Undenatured collagen capsules", "Native type 2 collagen", "Joint support collagen II", "Undenatured collagen powder", "Type 2 collagen for joints", "Bioactive collagen type II", "Undenatured joint collagen" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }